Business and Finance

Partnership eyes data-powered insights around international pricing and market access decision-making

Proposal also points to need for further resource investment to “enhance” FDA operations

Companies will work together on delivering improved patient access and clinical trial diversity

Deal gives leader in lab instruments and tests a big push into pharma service and clinical research space

The White House’s American Jobs Plan includes investment in new technologies for rapid scale up of vaccine production

Will purchase Hemmo Pharmaceuticals, one of India's largest producers of synthetic peptides

SK Capital renames CDMO business Woodstock Sterile Solutions

Acquisition further develops KD Pharma’s CDMO capabilities

Company markets unique approach to managing pharma supply chains

The big pharma will help fill and finish up to 60 million doses of Novavax' coronavirus candidate

Deal allows for more transport options, temperature control

Makes up to 400 million doses of J&J's Covid vaccine available to the African Union through 2022

Biomedical freezer maker to combine with supplier of cell and gene therapy tools

Cell culture facility expected to be largest in North America, according to the manufacturer

The commission is launching a broad review of drug-company mergers to explore how such deals can potentially harm industry competition

Production will occur at IDT’s Germany facilities for a three-month span

Agreement focused on enhancing insights into the location and condition of temperature-sensitive drugs and vaccines, including ones for Covid-19

Deal bolsters ANI’s generics and CDMO portfolio

More than $600 million in backing opens the door for additional manufacturing capacity, further Covid-19 preparations

Company’s rebranded platform, Ocellos, will manage complex handoffs in cell and gene therapy (CGT) treatments and trials

Agreements to focus on driving adoption of AI and natural language processing for medical affairs programs

The 130,000-square-foot site will be the CDMO's third location

Ten million doses expected by end of Q3

Partnership’s priority is to evaluate mental health medication

Marks the latest big pharma partnership for CureVac around its Covid vaccine candidate, CVnCoV